Kiniksa Pharmaceuticals International, plc ( KNSA) - Key Metrics

KNSA Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $3.14 $0.33 $0.61 $0.60
2026Q1 $2.80 $0.30 $0.66 $0.65
2025Q4 $2.72 $0.19 $0.73 $0.72
2025Q3 $2.46 $0.25 $0.46 $0.45
2025Q2 $2.14 $0.24 $0.38 $0.38

KNSA Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 48.45
2026Q1 0% 40.13
2025Q4 0% 54.28
2025Q3 0% 38.83
2025Q2 0% 28.82

KNSA Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.94% 0%
2026Q1 1.36% 0%
2025Q4 1.74% 0%
2025Q3 1.15% 0%
2025Q2 1.37% 0%

KNSA

Price: $79.48

52 week price:
35.20
82.94

Earnings Per Share: 0.99 USD

P/E Ratio: 74.15

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Bermuda

Volume: 221500

Market Capitalization: 5.9 billion

Links: